A. Ahr

From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

Oleg Schmidt‐Kittler, Thomas Ragg, Angela Daskalakis et al. · Proceedings of the National Academy of Sciences · 2003 · 624 citations · Full text

Medicine, Genetics, Oncology +17

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Uwe Holtrich, L. Pusztai et al. · Breast Cancer Research · 2009 · 482 citations · Full text

Medicine, Cancer Biology, Oncology +17

A clinically relevant gene signature in triple negative and basal-like breast cancer

Achim Rody, Thomas Karn, Cornelia Liedtke et al. · Breast Cancer Research · 2011 · 336 citations · Full text

Medicine, Cancer Biology, Oncology +17

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures

Thomas Karn, Lajos Pusztai, Uwe Holtrich et al. · PLoS ONE · 2011 · 93 citations · Full text

Medicine, Cancer Biology, Oncology +16

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

Achim Rody, Thomas Karn, R. Gätje et al. · The Breast · 2006 · 80 citations

Medicine, Oncology, Pharmacology +17